Arrowhead Pharmaceuticals · 14 hours ago
Specialist I, Supplier Quality
Arrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing RNAi-based therapies for intractable diseases. The Supplier Qualification Specialist I will support Supplier Quality Assurance with supplier qualification, regulatory compliance, and collaboration with internal and external teams.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Manage initial intake of new regulated suppliers from the business teams
Conduct or assist with supplier risk assessments
Coordinate with internal and external auditors performing supplier audits
Maintain supplier, audit, and qualification records within Veeva
Support Lead Auditors by tracking timelines and preparing required documentation
Maintain supplier licenses, certifications, and related compliance documentation within Veeva
Generate and distribute supplier metrics to QA groups and business stakeholders
Support Arrowhead audits and inspections
Assist with preparation, update, review, and routing of Arrowhead procedural documents
Support eQMS and other system implementations
Perform additional QA duties as needed
Qualification
Required
Associate's degree, with BS/BA preferred
1+ year of quality assurance experience
Ability to follow company procedures, work instructions, and policies
Competent knowledge of and ability to use Microsoft Word, Outlook, PowerPoint and Excel
Excellent attention to detail and organizational skills
Ability to multi-task and prioritize work with minimal supervision
Excellent interpersonal, verbal, and written communication skills
Preferred
Experience working in biotech or pharmaceutical development, manufacturing, or contract manufacturing organizations
Working knowledge of GMP, GCP, and/or GLP regulations
Prior experience with use of an electronic document management system in a regulated environment
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-14
Company data provided by crunchbase